login
login
Image header Agence Europe
Europe Daily Bulletin No. 12739
EU RESPONSE TO COVID-19 / Health

European Medicines Agency advises against use of AstraZeneca’s vaccine in people with a history of capillary leak syndrome

The European Medicines Agency’s (EMA) safety committee concluded on Friday 11 June that people who have already experienced capillary leak syndrome should not receive the vaccine developed by AstraZeneca.

This syndrome, the EMA recalls, is a very rare and serious condition that causes fluid leakage from small blood vessels, resulting in, among other things, “low blood pressure, thickening of the blood and low blood levels of albumin (an important blood protein)”.

The EMA has...

Contents

SECTORAL POLICIES
EU RESPONSE TO COVID-19
EXTERNAL ACTION
SECURITY - DEFENCE
ECONOMY - FINANCE
EUROPEAN PARLIAMENT PLENARY
SOCIAL AFFAIRS
EDUCATION - YOUTH - CULTURE - SPORT
G7 SUMMIT
COUNCIL OF EUROPE
NEWS BRIEFS
CALENDAR
CALENDAR EXTRA